SANTA CLARA, Calif.--(BUSINESS WIRE)--Intevac, Inc. (Nasdaq: IVAC) today reported financial results for the quarter and nine months ended September 29, 2018.
“Our third-quarter results were better than forecast, with stronger levels of upgrades in our Hard Disk Drive (HDD) equipment business, higher Photonics gross margin, and continued close control of expenses,” commented Wendell Blonigan, president and chief executive officer of Intevac. “We made significant progress in our Thin-film Equipment (TFE) growth initiatives during the third quarter, and witnessed increasing interest in the differentiated decorative coatings enabled by our system, including transitioning and gradient colors as well as patterned effects for backside cover glass. We remain confident that this remains a significant revenue opportunity for us, diversified from the HDD business, and the third quarter was an exciting one for us in terms of the level of engagement with the industry’s leading companies.
“In our HDD business, growth in media units in 2018 is well outpacing industry estimates entering the year. Due to the strong growth of multi-disk, high-capacity nearline drives for the cloud, our outlook for both upgrades and new systems for our HDD business has strengthened, with TFE backlog growing to an eight-year record. In Photonics, we were pleased to return to profitability in the third quarter, with a strong rebound in revenues over the previous two quarters. The approval of the U.S. Military’s budget is an encouraging sign for a return to growth in 2019, when we expect to see increasing demand for digital night-vision cameras for the Joint Strike Fighter and Apache programs.” Mr. Blonigan concluded, “Progress in our TFE growth initiatives in 2018 and a strengthening outlook for HDD media and Photonics gives us increasing confidence for a resumption of revenue growth in 2019.”
| ($ Millions, except per share amounts) | Q3 2018 | Q3 2017 | ||||||||||||
| GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||
| Net Revenues | $ | 19.5 | $ | 19.5 | $ | 26.7 | $ | 26.7 | ||||||
| Operating Income (Loss) | $ | (1.1 | ) | $ | (1.1 | ) | $ | 1.3 | $ | 1.0 | ||||
| Net Income (Loss) | $ | (1.1 | ) | $ | (1.1 | ) | $ | 1.2 | $ | 0.9 | ||||
| Net Income (Loss) per Share | $ | (0.05 | ) | $ | (0.05 | ) | $ | 0.05 | $ | 0.04 | ||||
|
|
Nine Months Ended | Nine Months Ended | ||||||||||||
| September 29, 2018 | September 30, 2017 | |||||||||||||
| GAAP Results | Non-GAAP Results | GAAP Results | Non-GAAP Results | |||||||||||
| Net Revenues | $ | 63.5 | $ | 63.5 | $ | 88.1 | $ | 88.1 | ||||||
| Operating Income (Loss) | $ | (6.1 | ) | $ | (6.0 | ) | $ | 4.7 | $ | 4.5 | ||||
| Net Income (Loss) | $ | (6.4 | ) | $ | (6.3 | ) | $ | 4.2 | $ | 4.0 | ||||
| Net Income (Loss) per Share | $ | (0.29 | ) | $ | (0.28 | ) | $ | 0.18 | $ | 0.17 | ||||
Intevac’s non-GAAP adjusted results exclude the impact of the following, where applicable: (1) changes in fair value of contingent consideration liabilities associated with business combinations; and (2) restructuring charges. A reconciliation of the GAAP and non-GAAP adjusted results is provided in the financial table included in this release. See also “Use of Non-GAAP Financial Measures” section.
Third Quarter 2018 Summary
The net loss for the quarter was $1.1 million, or $0.05 per diluted share, compared to net income of $1.2 million, or $0.05 per diluted share, in the third quarter of 2017. The non-GAAP net loss was $1.1 million or $0.05 per diluted share. This compares to the third quarter 2017 non-GAAP net income of $947,000 or $0.04 per diluted share.
Revenues were $19.5 million, including $12.1 million of TFE revenues and Photonics revenues of $7.4 million. TFE revenues included upgrades, spares and service. Photonics revenues included $2.3 million of research and development contracts. In the third quarter of 2017, revenues were $26.7 million, including $17.2 million of TFE revenues, which consisted of two 200 Lean HDD systems, upgrades, spares and service, and Photonics revenues of $9.5 million, which included $2.2 million of research and development contracts.
TFE gross margin was 40.2% compared to 45.5% in the third quarter of 2017 and 41.7% in the second quarter of 2018. The decline from the third quarter of 2017 and the second quarter of 2018 reflected a lower level of revenue and lower factory absorption.
Photonics gross margin was 35.5% compared to 36.5% in the third quarter of 2017 and 20.4% in the second quarter of 2018. The decline from the third quarter of 2017 was primarily due to lower revenue levels and a higher mix of lower-margin research and development contracts. The improvement from the second quarter of 2018 was primarily due to higher revenue levels and favorable product mix. Consolidated gross margin was 38.5%, compared to 42.3% in the third quarter of 2017 and 37.4% in the second quarter of 2018.
R&D and SG&A expenses were $8.6 million, compared to $10.3 million in the third quarter of 2017 and $9.7 million in the second quarter of 2018. The lower level of expenses primarily reflects cost control initiatives implemented in the first quarter of 2018.
Order backlog totaled $72.2 million on September 29, 2018, compared to $64.6 million on June 30, 2018 and $72.8 million on September 30, 2017. Backlog at both September 29, 2018 and June 30, 2018 included three 200 Lean HDD systems and twelve ENERGi solar ion implant systems. Backlog at September 30, 2017 included five 200 Lean HDD systems and twelve ENERGi solar ion implant systems.
The Company ended the quarter with $45.7 million of total cash, restricted cash and investments and $78.3 million in tangible book value.
First Nine Months 2018 Summary
The net loss was $6.4 million, or $0.29 per diluted share, compared to net income of $4.2 million, or $0.18 per diluted share, for the first nine months of 2017. The non-GAAP net loss was $6.3 million or $0.28 per diluted share. This compares to the first nine months of 2017 non-GAAP net income of $4.0 million or $0.17 per diluted share.
Revenues were $63.5 million, including $45.7 million of TFE revenues and Photonics revenues of $17.8 million, compared to revenues of $88.1 million, including $61.1 million of TFE revenues and Photonics revenues of $27.0 million, for the first nine months of 2017. We recognized revenue on three 200 Lean HDD systems in the first nine months of 2018. We recognized revenue on four 200 Lean HDD systems, one pilot INTEVAC MATRIX solar ion implant system, two ENERGi solar ion implant systems and four VERTEX coating systems for display cover panels in the first nine months of 2017.
TFE gross margin was 39.6%, compared to 42.0% in the first nine months of 2017. The decline from the first nine months of 2017 reflected a lower level of revenue and lower factory absorption. Photonics gross margin was 22.5% compared to 37.5% in the first nine months of 2017. The decline from the first nine months of 2017 was primarily due lower revenue levels, a higher mix of lower-margin research and development contracts and incremental loss provisions recorded on several contracts. Consolidated gross margin was 34.8%, compared to 40.7% in the first nine months of 2017.
R&D and SG&A expenses were $28.3 million compared to $31.3 million in the first nine months of 2017. The lower level of expenses reflects cost control initiatives implemented in the first quarter of 2018, lower legal expenses for patent activity and contracts and decreased accruals for variable compensation programs.
Use of Non-GAAP Financial Measures
Intevac's non-GAAP results exclude the impact of the following, where applicable: changes in fair value of contingent consideration liabilities associated with business combinations and restructuring. A reconciliation of the GAAP and non-GAAP results is provided in the financial tables included in this release.
Management uses non-GAAP results to evaluate the Company’s operating and financial performance in light of business objectives and for planning purposes. These measures are not in accordance with GAAP and may differ from non-GAAP methods of accounting and reporting used by other companies. Intevac believes these measures enhance investors’ ability to review the Company’s business from the same perspective as the Company’s management and facilitate comparisons of this period’s results with prior periods. The presentation of this additional information should not be considered a substitute for results prepared in accordance with GAAP.
Conference Call Information
The Company will discuss its financial results and outlook in a conference call today at 1:30 p.m. PDT (4:30 p.m. EDT). To participate in the teleconference, please call toll-free (877) 334-0811 prior to the start time. For international callers, the dial-in number is (408) 427-3734. You may also listen live via the Internet at the Company's website, www.intevac.com, under the Investors link, or at www.earnings.com. For those unable to attend, these web sites will host an archive of the call. Additionally, a telephone replay of the call will be available for 48 hours beginning today at 7:30 p.m. EDT. You may access the replay by calling (855) 859-2056 or, for international callers, (404) 537-3406, and providing Replay Passcode 7267648.
About Intevac
Intevac was founded in 1991 and has two businesses: Thin-Film Equipment and Photonics.
In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently.
In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most U.S. military night vision programs.
For more information call 408-986-9888, or visit the Company's website at www.intevac.com.
200 Lean®, INTEVAC MATRIX®, INTEVAC VERTEX®, oDLC® and ENERGi® are registered trademarks of Intevac, Inc.
Safe Harbor Statement
This press release includes statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Intevac claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms “may,” “believes,” “projects,” “expects,” or “anticipates,” and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: customer adoption of our products, an increase in the revenue opportunity pipeline for Photonics, and the future financial performance of Intevac, such as achieving profitability. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the Company’s expectations. These risks include, but are not limited to: technology risk and challenges achieving customer adoption and revenue recognition in Thin-film Equipment markets and delays in Photonics programs, each of which could have a material impact on our business, our financial results, and the Company's stock price. These risks and other factors are detailed in the Company’s periodic filings with the U.S. Securities and Exchange Commission.
|
INTEVAC, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, in thousands, except per share amounts) |
|||||||||||||||||
| Three months ended | Nine months ended | ||||||||||||||||
|
September 29, |
September 30, |
September 29, |
September 30, |
||||||||||||||
| Net revenues | |||||||||||||||||
| TFE | $ | 12,108 | $ | 17,177 | $ | 45,745 | $ | 61,087 | |||||||||
| Photonics | 7,358 | 9,549 | 17,793 | 26,990 | |||||||||||||
| Total net revenues | 19,466 | 26,726 | 63,538 | 88,077 | |||||||||||||
| Gross profit | 7,486 | 11,298 | 22,122 | 35,816 | |||||||||||||
| Gross margin | |||||||||||||||||
| TFE | 40.2 | % | 45.5 | % | 39.6 | % | 42.0 | % | |||||||||
| Photonics | 35.5 | % | 36.5 | % | 22.5 | % | 37.5 | % | |||||||||
| Consolidated | 38.5 | % | 42.3 | % | 34.8 | % | 40.7 | % | |||||||||
| Operating expenses | |||||||||||||||||
| Research and development | 3,737 | 4,535 | 12,889 | 13,635 | |||||||||||||
| Selling, general and administrative | 4,842 | 5,778 | 15,374 | 17,663 | |||||||||||||
| Acquisition-related1 | — | (283 | ) | 8 | (181 | ) | |||||||||||
| Total operating expenses | 8,579 | 10,030 | 28,271 | 31,117 | |||||||||||||
| Total operating income (loss) | (1,093 | ) | 1,268 | (6,149 | ) | 4,699 | |||||||||||
| Operating income (loss) | |||||||||||||||||
| TFE | (907 | ) | 1,213 | (2,197 | ) | 4,821 | |||||||||||
| Photonics | 688 | 1,417 | (966 | ) | 3,646 | ||||||||||||
| Corporate | (874 | ) | (1,362 | ) | (2,986 | ) | (3,768 | ) | |||||||||
| Total operating income (loss) | (1,093 | ) | 1,268 | (6,149 | ) | 4,699 | |||||||||||
| Interest income and other income (expense), net | 186 | 28 | 464 | 265 | |||||||||||||
| Net income (loss) before income taxes | (907 | ) | 1,296 | (5,685 | ) | 4,964 | |||||||||||
| Provision for income taxes | 192 | 66 | 717 | 805 | |||||||||||||
| Net income (loss) | $ | (1,099 | ) | $ | 1,230 | $ | (6,402 | ) | $ | 4,159 | |||||||
| Net income (loss) per share | |||||||||||||||||
| Basic | $ | (0.05 | ) | $ | 0.06 | $ | (0.29 | ) | $ | 0.19 | |||||||
| Diluted | $ | (0.05 | ) | $ | 0.05 | $ | (0.29 | ) | $ | 0.18 | |||||||
| Weighted average common shares outstanding | |||||||||||||||||
| Basic | 22,719 | 21,714 | 22,429 | 21,475 | |||||||||||||
| Diluted | 22,719 | 22,970 | 22,429 | 22,989 | |||||||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
|
INTEVAC, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except par value) |
||||||||
|
September 29, |
December 30, |
|||||||
| (Unaudited) | (see Note) | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash, cash equivalents and short-term investments | $ | 38,928 | $ | 35,639 | ||||
| Accounts receivable, net | 18,835 | 20,474 | ||||||
| Inventories | 34,679 | 33,792 | ||||||
| Prepaid expenses and other current assets | 2,610 | 2,524 | ||||||
| Total current assets | 95,052 | 92,429 | ||||||
| Long-term investments | 5,164 | 6,849 | ||||||
| Restricted cash | 1,569 | 1,000 | ||||||
| Property, plant and equipment, net | 11,046 | 12,478 | ||||||
| Intangible assets, net | 1,042 | 1,503 | ||||||
| Other long-term assets | 744 | 764 | ||||||
| Total assets | $ | 114,617 | $ | 115,023 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | 5,956 | $ | 3,949 | ||||
| Accrued payroll and related liabilities | 4,272 | 6,818 | ||||||
| Other accrued liabilities | 10,995 | 7,688 | ||||||
| Customer advances | 11,616 | 11,026 | ||||||
| Total current liabilities | 32,839 | 29,481 | ||||||
| Other long-term liabilities | 2,436 | 2,879 | ||||||
| Stockholders’ equity | ||||||||
| Common stock ($0.001 par value) | 23 | 22 | ||||||
| Additional paid-in capital | 182,354 | 177,521 | ||||||
| Treasury stock, at cost | (28,489 | ) | (28,489 | ) | ||||
| Accumulated other comprehensive income | 371 | 490 | ||||||
| Accumulated deficit | (74,917 | ) | (66,881 | ) | ||||
| Total stockholders’ equity | 79,342 | 82,663 | ||||||
| Total liabilities and stockholders’ equity | $ | 114,617 | $ | 115,023 | ||||
Note: Amounts as of December 30, 2017 are derived from the December 30, 2017 audited consolidated financial statements.
|
INTEVAC, INC. RECONCILIATION OF GAAP TO NON-GAAP RESULTS (Unaudited, in thousands, except per share amounts) |
||||||||||||||||
| Three months ended | Nine months ended | |||||||||||||||
|
September 29, |
September 30, |
September 29, |
September 30, |
|||||||||||||
| Non-GAAP Income (Loss) from Operations | ||||||||||||||||
| Reported operating income (loss) (GAAP basis) | $ | (1,093 | ) | $ | 1,268 | $ | (6,149 | ) | $ | 4,699 | ||||||
| Change in fair value of contingent consideration obligations1 | — | (283 | ) | 8 | (181 | ) | ||||||||||
| Restructuring charges2 | — | — | 95 | — | ||||||||||||
| Non-GAAP Operating Income (Loss) | $ | (1,093 | ) | $ | 985 | $ | (6,046 | ) | $ | 4,518 | ||||||
| Non-GAAP Net Income (Loss) | ||||||||||||||||
| Reported net income (loss) (GAAP basis) | $ | (1,099 | ) | $ | 1,230 | $ | (6,402 | ) | $ | 4,159 | ||||||
| Change in fair value of contingent consideration obligations1 | — | (283 | ) | 8 | (181 | ) | ||||||||||
| Restructuring charges2 | — | — | 95 | — | ||||||||||||
| Non-GAAP Net Income (Loss) | $ | (1,099 | ) | $ | 947 | $ | (6,299 | ) | $ | 3,978 | ||||||
| Non-GAAP Net Income (Loss) Per Diluted Share | ||||||||||||||||
| Reported net income (loss) per diluted share (GAAP basis) | $ | (0.05 | ) | $ | 0.05 | $ | (0.29 | ) | $ | 0.18 | ||||||
| Change in fair value of contingent consideration obligations1 | — | (0.01 | ) | — | (0.01 | ) | ||||||||||
| Restructuring charges2 | — | — | — | — | ||||||||||||
| Non-GAAP Net Income (Loss) Per Diluted Share | $ | (0.05 | ) | $ | 0.04 | $ | (0.28 | ) | $ | 0.17 | ||||||
| Weighted average number of diluted shares | 22,719 | 22,970 | 22,429 | 22,989 | ||||||||||||
1Results for all periods presented include changes in fair value of contingent consideration obligations associated with the Solar Implant Technology (SIT) acquisition in 2010.
2Results for the nine months ended September 29, 2018 include severance and other employee-related costs related to a restructuring program.
